Skip to main content
Top
Published in: International Journal of Hematology 4/2011

01-10-2011 | Case Report

Empty sella/pituitary atrophy and endocrine impairments as a consequence of radiation and chemotherapy in long-term survivors of childhood leukemia

Authors: Yoshikazu Nishi, Kazuko Hamamoto, Naoto Fujita, Satoshi Okada

Published in: International Journal of Hematology | Issue 4/2011

Login to get access

Abstract

Radiation-induced empty sella (ES) or pituitary atrophy/small pituitary and endocrine impairments, including pituitary and gonadal dysfunction, can manifest decades after radiation and chemotherapy in childhood-onset leukemia patients who received prophylactic cranial irradiation or total body irradiation in preparation for bone marrow transplant. Six childhood-onset leukemia patients (age at diagnosis of leukemia; 2.7–10.2 years) participated in this study. Magnetic resonance imaging (MRI) of the pituitary gland and endocrinological studies were performed 10.5–32.1 years after cranial irradiation. In four of the six patients examined, ES or pituitary atrophy was detected approximately 10.5–19.8 years after cranial irradiation. Four patients had hypogonadism (primary, 3; hypothalamic-pituitary, 1) and one had primary hypothyroidism. We conclude that ES or pituitary atrophy and endocrine impairments can manifest decades after radiation and chemotherapy in childhood-onset leukemia. These patients should, therefore, undergo regular follow-up, including pituitary MRI and hormonal examinations.
Literature
1.
go back to reference Edgar AB, Morris EMM, Kelnar CJH, et al. Long-term follow-up survivors of childhood cancer. Endocr Dev. 2009;15:159–80.CrossRefPubMed Edgar AB, Morris EMM, Kelnar CJH, et al. Long-term follow-up survivors of childhood cancer. Endocr Dev. 2009;15:159–80.CrossRefPubMed
2.
go back to reference Nandagopal R, Laverdière C, Mulrooney D, et al. Endocrine late effects of childhood cancer therapy: a report from the children’s oncology group. Horm Res. 2008;69:65–74.PubMed Nandagopal R, Laverdière C, Mulrooney D, et al. Endocrine late effects of childhood cancer therapy: a report from the children’s oncology group. Horm Res. 2008;69:65–74.PubMed
3.
go back to reference Darzy KH, Shalet SM. Hypopituitarism as a consequence of brain tumours and radiotherapy. Pituitary. 2005;8:203–11.CrossRefPubMed Darzy KH, Shalet SM. Hypopituitarism as a consequence of brain tumours and radiotherapy. Pituitary. 2005;8:203–11.CrossRefPubMed
4.
go back to reference Cohen LE. Endocrine late effects of cancer treatment. Endocrinol Metab Clin N Am. 2005;34:769–89.CrossRef Cohen LE. Endocrine late effects of cancer treatment. Endocrinol Metab Clin N Am. 2005;34:769–89.CrossRef
5.
go back to reference Marinis LD, Bonadonna S, Bianchi A, et al. Extensive clinical experience. Primary empty sella. J Clin Endocrinol Metab. 2005;90:5471–7.CrossRefPubMed Marinis LD, Bonadonna S, Bianchi A, et al. Extensive clinical experience. Primary empty sella. J Clin Endocrinol Metab. 2005;90:5471–7.CrossRefPubMed
6.
go back to reference Tsunoda A, Okuda O, Sato K. MR height of the pituitary gland as a function of age and sex: especially physiological hypertrophy in adolescence and in climacterium. Am J Neuroradiol. 1997;18:551–4.PubMed Tsunoda A, Okuda O, Sato K. MR height of the pituitary gland as a function of age and sex: especially physiological hypertrophy in adolescence and in climacterium. Am J Neuroradiol. 1997;18:551–4.PubMed
7.
go back to reference Suzuki M, Takashima T, Kadoya M, et al. Height of normal pituitary gland on MR imaging: age and sex differentiation. J Comput Assist Tomogr. 1990;14:36–9.CrossRefPubMed Suzuki M, Takashima T, Kadoya M, et al. Height of normal pituitary gland on MR imaging: age and sex differentiation. J Comput Assist Tomogr. 1990;14:36–9.CrossRefPubMed
8.
go back to reference Cannavò S, Curtò L, Venturino M, et al. Abnormalities of hypothalamic-pituitary–thyroid axis in patients with primary empty sella. J Endocrinol Invest. 2002;25:236–9.CrossRefPubMed Cannavò S, Curtò L, Venturino M, et al. Abnormalities of hypothalamic-pituitary–thyroid axis in patients with primary empty sella. J Endocrinol Invest. 2002;25:236–9.CrossRefPubMed
Metadata
Title
Empty sella/pituitary atrophy and endocrine impairments as a consequence of radiation and chemotherapy in long-term survivors of childhood leukemia
Authors
Yoshikazu Nishi
Kazuko Hamamoto
Naoto Fujita
Satoshi Okada
Publication date
01-10-2011
Publisher
Springer Japan
Published in
International Journal of Hematology / Issue 4/2011
Print ISSN: 0925-5710
Electronic ISSN: 1865-3774
DOI
https://doi.org/10.1007/s12185-011-0939-z

Other articles of this Issue 4/2011

International Journal of Hematology 4/2011 Go to the issue
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine